Skip to content

Optic Nerve Head Strain as Biomarker for Glaucoma

Optic Nerve Head Strain as Biomarker for Glaucoma

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06240312
Enrollment
130
Registered
2024-02-05
Start date
2024-07-01
Completion date
2028-01-31
Last updated
2026-06-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma, Open-Angle

Brief summary

The investigators will test the hypothesis that images of the optic nerve head taken a 2 different eye pressures will yield strain estimates that are predictive of the course of glaucoma.

Detailed description

Existing glaucoma patients and suitable control adults will be imaged with an FDA-approved optical coherence tomography instrument. Those who are imaged at 2 different eye pressures will generate biomechanical strain estimates. These will be compared to visual field and retinal nerve fiber layer measurements over time. The investigators expect that baseline strain and their changes over time will be associated with progression rate of glaucoma damage, providing a biomarker for susceptibility.

Interventions

DEVICEImages of eye at 2 eye pressures

subject images of the eye's optic nerve head are studied

Sponsors

Johns Hopkins University
Lead SponsorOTHER
National Eye Institute (NEI)
CollaboratorNIH

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
Yes

Inclusion criteria

* Existing glaucoma patients of Johns Hopkins

Exclusion criteria

* Inability to perform imaging * illiterate * hearing impaired * non-English speakers

Design outcomes

Primary

MeasureTime frameDescription
Optic nerve head mechanical strain compared to visual field change over timeApproximately 3 yearsStrains measured at baseline are tested for association with glaucoma course

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORHarry Quigley

Johns Hopkins School of Medicine

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 11, 2026